相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。LaPO4 Nanoparticles Doped with Actinium-225 that Partially Sequester Daughter Radionuclides
Jonathan Woodward et al.
BIOCONJUGATE CHEMISTRY (2011)
Alpha- versus Beta-Particle Radiopeptide Therapy in a Human Prostate Cancer Model (213Bi-DOTA-PESIN and 213Bi-AMBA versus 177Lu-DOTA-PESIN)
Damian Wild et al.
CANCER RESEARCH (2011)
Towards translation of Pb-212 as a clinical therapeutic; getting the lead in!
Kwon Yong et al.
DALTON TRANSACTIONS (2011)
The best radionuclide for radioimmunotherapy of small tumors: beta- or alpha-emitter?
Jacques Barbet et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2011)
TREATMENT OF HER2-EXPRESSING BREAST CANCER AND OVARIAN CANCER CELLS WITH ALPHA PARTICLE-EMITTING 227TH-TRASTUZUMAB
Helen Heyerdahl et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
Conventional and pretargeted radioimmunotherapy using bismuth-213 to target and treat non-Hodgkin lymphomas expressing CD20: a preclinical model toward optimal consolidation therapy to eradicate minimal residual disease
Steven I. Park et al.
BLOOD (2010)
Improved Efficacy of α-Particle-Targeted Radiation Therapy
Diane E. Milenic et al.
CANCER (2010)
Immunoliposomal Delivery of 213Bi for α-Emitter Targeting of Metastatic Breast Cancer
Mohanambe Lingappa et al.
CANCER RESEARCH (2010)
Sequential Cytarabine and α-Particle Immunotherapy with Bismuth-213-Lintuzumab (HuM195) for Acute Myeloid Leukemia
Todd L. Rosenblat et al.
CLINICAL CANCER RESEARCH (2010)
Assessment of long-term radiotoxicity after treatment with the low-dose-rate alpha-particle-emitting radioimmunoconjugate Th-227-rituximab
Jostein Dahle et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
Alpha particles more promising than toxins?
Jacques Barbet et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
Targeted alpha-radionuclide therapy of functionally critically located gliomas with 213Bi-DOTA-[Thi8,Met(O2)11]-substance P: a pilot trial
D. Cordier et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
Reagents for Astatination of Biomolecules. 4. Comparison of Maleimido-closo-Decaborate(2-) and meta-[211At]Astatobenzoate Conjugates for Labeling anti-CD45 Antibodies with [211At]Astatine
D. Scott Wilbur et al.
BIOCONJUGATE CHEMISTRY (2009)
Biodistributions, Myelosuppression, and Toxicities in Mice Treated with an Anti-CD45 Antibody Labeled with the α-Emitting Radionuclides Bismuth-213 or Astatine-211
Hirohisa Nakamae et al.
CANCER RESEARCH (2009)
Radioimmunotherapy of Breast Cancer Metastases with α-Particle Emitter 225Ac: Comparing Efficacy with 213Bi and 90Y
Hong Song et al.
CANCER RESEARCH (2009)
Intraperitoneal α-Particle Radioimmunotherapy of Ovarian Cancer Patients: Pharmacokinetics and Dosimetry of 211At-MX35 F(ab′)2-A Phase I Study
Hakan Andersson et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Treatment of HER2-positive breast carcinomatous meningitis with intrathecal administration of α-particle-emitting 211At-labeled trastuzumab
Abraham Boskovitz et al.
NUCLEAR MEDICINE AND BIOLOGY (2009)
Alpha-particles for targeted therapy
George Sgouros
ADVANCED DRUG DELIVERY REVIEWS (2008)
Realizing the potential of the Actinium-225 radionuclide generator in targeted alpha particle therapy applications
Matthias Miederer et al.
ADVANCED DRUG DELIVERY REVIEWS (2008)
Bismuth-213 radioimmunotherapy with C595 anti-MUC1 monoclonal antibody in an ovarian cancer ascites model
Emma Y. Song et al.
CANCER BIOLOGY & THERAPY (2008)
Preparation and testing of bevacizumab radioimmunoconjugates with bismuth-213 and bismuth-205/bismuth-206
Syed M. Abbas Rizvi et al.
CANCER BIOLOGY & THERAPY (2008)
213Bi (α-emitter)-antibody targeting of breast cancer metastases in the neu-N transgenic mouse model
Hong Song et al.
CANCER RESEARCH (2008)
Multimodality therapy: Potentiation of high linear energy transfer radiation with paclitaxel for the treatment of disseminated peritoneal disease
Diane E. Milenic et al.
CLINICAL CANCER RESEARCH (2008)
Relative biologic effects of low-dose-rate α-emitting 227Th-rituximab and β-emitting 90Y-tiuexetan-ibritumomab versus external beam X-radiation
Jostein Dahle et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Feasibility of the radioastatination of a monoclonal antibody with astatine-211 purified by wet extraction
Mickael Bourgeois et al.
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS (2008)
Clinical experience with alpha-particle-emitting At-211: Treatment of recurrent brain tumor patients with At-211-labeled chimeric antitenascin monoclonal antibody 81C6
Michael R. Zalutsky et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Enhanced retention of the α-particle-emitting daughters of actinium-225 by liposome carriers
Stavroula Sofou et al.
BIOCONJUGATE CHEMISTRY (2007)
Targeted α-particle radiotherapy with 211At-labeled monoclonal antibodies
Michael R. Zalutsky et al.
NUCLEAR MEDICINE AND BIOLOGY (2007)
Therapeutic efficacy of astatine-211-labeled trastuzumab on radioresistant SKOV-3 tumors in nude mice
Stig Palm et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
Targeted cancer therapy with a novel low-dose rate α-emitting radioimmunoconjugate
Jostein Dahle et al.
BLOOD (2007)
Biodistribution of 211At-Labeled humanized monoclonal antibody A33
Ylva Almqvist et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2007)
Interim analysis of oxicity and response in phase 1 trial of systemic targeted alpha therapy for metastatic melanoma
Chand Raja et al.
CANCER BIOLOGY & THERAPY (2007)
Preparation of TH227-labeled radioimmunoconjugates, assessment of serum stability and antigen binding ability
Roy H. Larsen et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2007)
Radioimmunotherapy with astatine-211 using chimeric monoclonal antibody U36 in head and neck squamous cell carcinoma
Junping Cheng et al.
LARYNGOSCOPE (2007)
Potentiation of high-LET radiation by gemcitabine: Targeting HER2 with trastuzumab to treat disseminated peritoneal disease
Diane E. Milenic et al.
CLINICAL CANCER RESEARCH (2007)
Selective Alpha-Particle Mediated Depletion of Tumor Vasculature with Vascular Normalization
Jaspreet Singh Jaggi et al.
PLOS ONE (2007)
Targeted α-therapy:: past, present, future?
Martin W. Brechbiel
DALTON TRANSACTIONS (2007)
Development and application of peptide-based radiopharmaccuticals
Ingrid Dijkgraaf et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2007)
Administered activity and metastatic cure probability during radioimmunotherapy of ovarian cancer in nude mice with 211At-MX35 F(ab′)2
Jorgen Elgqvist et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
The anti-CD25 monoclonal antibody 7G7/B6, armed with the α-emitter 211At, provides effective radioimmunotherapy for a murine model of leukemia
Meili Zhang et al.
CANCER RESEARCH (2006)
Effective treatment of a murine model of adult T-cell leukemia using 211At-7G7/B6 and its combination with unmodified anti-Tac (daclizumab) directed toward CD25
Zhuo Zhang et al.
BLOOD (2006)
Local targeting of malignant gliomas by the diffusible peptidic vector 1,4,7,10-tetraazacyclododecane-1-glutaric acid-4,7,10-triacetic acid-substance P
Stefan Kneifel et al.
CLINICAL CANCER RESEARCH (2006)
Preclinical studies of Bismuth-213 labeled plasminogen activator inhibitor type 2 (PAI2) in a prostate cancer nude mouse xenograft model
Syed M. Abbas Rizvi et al.
CANCER BIOLOGY & THERAPY (2006)
Cytotoxicity of PAI2, C595 and Herceptin vectors labeled with the alpha-emitting radioisotope Bismuth-213 for ovarian cancer cell monolayers and clusters
YJ Song et al.
CANCER LETTERS (2006)
Initial evaluation of 227Th-p-benzyl-DOTA-rituximab for low-dose rate α-particle radioimmunotherapy
J Dahle et al.
NUCLEAR MEDICINE AND BIOLOGY (2006)
In vitro evaluation of the astatinated chimeric monoclonal antibody U36, a potential candidate for treatment of head and neck squamous cell carcinoma
M Nestor et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2005)
Fractionated locoregional low-dose radioimmunotherapy improves survival in a mouse model of diffuse-type gastric cancer using a 213Bi-conjugated monoclonal antibody
S Bloechl et al.
CLINICAL CANCER RESEARCH (2005)
Pretargeted radioimmunotherapy in tumored mice using an in vivo 212Pb/212Bi generator
FM Su et al.
NUCLEAR MEDICINE AND BIOLOGY (2005)
α-particle radioimmunotherapy of disseminated peritoneal disease using a 212Pb-labeled radioimmunoconjugate targeting HER2
DE Milenic et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2005)
In vitro characterization of 211At-labeled antibody A33 -: a potential therapeutic agent against metastatic colorectal carcinoma
Y Almqvist et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2005)
Melanoma therapy via peptide-targeted α-radiation
YB Miao et al.
CLINICAL CANCER RESEARCH (2005)
In vivo studies of pharmacokinetics and efficacy of bismuth-213 labeled antimelanoma monoclonal antibody 9.2.27
SMA Rizvi et al.
CANCER BIOLOGY & THERAPY (2005)
Production of actinium-225 for alpha particle mediated radioimmunotherapy
RA Boll et al.
APPLIED RADIATION AND ISOTOPES (2005)
Cancer radioimmunotherapy with alpha-emitting nuclides
O Couturier et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2005)
Wet harvesting of no-carrier-added At-211 from an irradiated Bi-209 target for radiopharmaceutical applications
AT Yordanov et al.
JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY (2004)
Vascular targeted endoradiotherapy of tumors using alpha-particle-emitting compounds: Theoretical analysis
G Akabani et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2002)
Tumor therapy with targeted atomic nanogenerators
MR McDevitt et al.
SCIENCE (2001)
Breakthrough of 225Ac and its radionuclide daughters from an 225Ac/213Bi generator:: development of new methods, quantitative characterization, and implications for clinical use
DH Ma et al.
APPLIED RADIATION AND ISOTOPES (2001)
Rapid preparation of short-lived alpha particle emitting radioimmunopharmaceuticals
DH Ma et al.
APPLIED RADIATION AND ISOTOPES (2001)
Advancements in cancer therapy with alpha-emitters: A review
SK Imam
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2001)
Synthesis, conjugation, and radiolabeling of a novel bifunctional chelating agent for 225Ac radioimmunotherapy applications
LL Chappell et al.
BIOCONJUGATE CHEMISTRY (2000)
The centenary of a controversial discovery: actinium
JP Adloff
RADIOCHIMICA ACTA (2000)
Synthesis, characterization, and evaluation of a novel bifunctional chelating agent for the lead isotopes Pb-203 and Pb-212
LL Chappell et al.
NUCLEAR MEDICINE AND BIOLOGY (2000)
Astatine-211-labeled radiotherapeutics: An emerging approach to targeted alpha-particle radiotherapy
MR Zalutsky et al.
CURRENT PHARMACEUTICAL DESIGN (2000)
分享论文
